Search results
Alzheimer’s Disease Drug Donanemab Gets Unanimous Backing From FDA Expert Panel
Forbes· 6 days agoA Food and Drug Administration expert panel of advisors voted 11-0 yesterday to recommend that the...
The FDA Should Reject MDMA Therapy—but Not for the Reasons You Think
Slate· 3 days agoDrug Administration voted 9–2 that Lykos Therapeutics, a company developing psychedelic drug...
AFA responds to approval of Alzheimer’s Drug by FDA Advisory Committee
KTVF Fairbanks· 4 days agoThe U.S. Food and Drug Administration (FDA) Advisory Committee, has approved the Alzheimer’s drug, donanemab. In phase ...
FDA approves AstraZeneca’s Farxiga for paediatric T2D patients
Pharmaceutical Technology via Yahoo Finance· 4 days agoIn addition to its use in diabetes management, Forxiga is approved in more than 100 countries for...
Unanimous FDA panel backs Lilly Alzheimer's drug
Axios· 6 days agoIt would compete with Eisai and Biogen's Leqembi, which the FDA approved last year. The FDA called for an outside review of donanemab ...
Alzheimer's drug that can slow disease gets backing from FDA advisers
KRCG· 6 days agoFood and Drug Administration advisers voted unanimously that the drug's ability to modestly slow the...
Alzheimer's drug that can slow disease gets backing from FDA advisers
WSB Radio· 6 days ago“I thought the evidence was very strong in the trial showing the effectiveness of the drug,” said panel member Dean Follmann, a statistician from the National Institutes of ...
Geron (GERN) Wins FDA Approval for Blood Cancer Drug, Stock Up
Zacks via Yahoo Finance· 6 days agoGeron's (GERN) shares rise on approval of its first drug. The FDA approves imetelstat for the...
FDA panel backs Alzheimer's drug that can reportedly slow cognitive decline
Scripps News via AOL· 5 days agoIf federal regulators agree with the panel's recommendation, it could become just the second drug ...
Eli Lilly (LLY) Alzheimer's Drug Donanemab Gets FDA Panel Nod
Zacks via Yahoo Finance· 5 days agoThe FDA is expected to give its decision later this year, which may or may not align with the PCNS...